Literature DB >> 9234810

Synthesis, stability, and subcellular distribution of major histocompatibility complex class II molecules in Langerhans cells infected with Leishmania major.

S Flohé1, T Lang, H Moll.   

Abstract

Protozoan parasites of the genus Leishmania exist as obligatory intracellular amastigotes and invade macrophages and Langerhans cells, the dendritic cells of the skin. Langerhans cells are much more efficient in presenting Leishmania major antigen to T cells than macrophages are and have the unique ability to retain parasite antigen in immunogenic form for prolonged periods. To analyze the mechanisms that are responsible for this potency, we defined the synthesis, turnover, conformation, and localization of major histocompatibility complex (MHC) class II molecules in Langerhans cells. Hence, Langerhans cells were pulse-labeled; immunoprecipitation of MHC class II molecules and gel electrophoresis followed. In addition, the subcellular distribution of MHC class II molecules in L. major-infected Langerhans cells was analyzed by confocal microscopy. The results show that (i) newly synthesized MHC class II molecules are required for L. major antigen presentation by Langerhans cells, (ii) MHC class II-peptide complexes in Langerhans cells are long-lived, (iii) phagocytosis of L. major modulates MHC class II biosynthesis by reducing its downregulation during Langerhans cell differentiation, and (iv) newly synthesized MHC class II molecules are associated with the parasitophorous vacuole of infected Langerhans cells. These findings support the conclusion that the traits of MHC class II expression correspond to the highly specialized functions of Langerhans cells in the immunoregulation of cutaneous leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234810      PMCID: PMC175487          DOI: 10.1128/iai.65.8.3444-3450.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Endocytosis by antigen presenting cells: dendritic cells are as endocytically active as other antigen presenting cells.

Authors:  T P Levine; B M Chain
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 2.  How MHC class II molecules work: peptide-dependent completion of protein folding.

Authors:  S Sadegh-Nasseri; R N Germain
Journal:  Immunol Today       Date:  1992-02

3.  MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding.

Authors:  R N Germain; L R Hendrix
Journal:  Nature       Date:  1991-09-12       Impact factor: 49.962

4.  Isolation and characterization of the intracellular MHC class II compartment.

Authors:  A Tulp; D Verwoerd; B Dobberstein; H L Ploegh; J Pieters
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

Review 5.  Experimental cutaneous leishmaniasis: Langerhans cells internalize Leishmania major and induce an antigen-specific T-cell response.

Authors:  H Moll
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

6.  Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis.

Authors:  A Will; C Blank; M Röllinghoff; H Moll
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

7.  Antigens targeted to the Leishmania phagolysosome are processed for CD4+ T cell recognition.

Authors:  P M Kaye; C Coburn; M McCrossan; S M Beverley
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

8.  Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.

Authors:  H Moll; H Fuchs; C Blank; M Röllinghoff
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

9.  Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major.

Authors:  C Blank; H Fuchs; K Rappersberger; M Röllinghoff; H Moll
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

10.  Distribution of MHC class I and of MHC class II molecules in macrophages infected with Leishmania amazonensis.

Authors:  T Lang; C de Chastellier; C Frehel; R Hellio; P Metezeau; S de S Leao; J C Antoine
Journal:  J Cell Sci       Date:  1994-01       Impact factor: 5.285

View more
  6 in total

1.  Amastigote load and cell surface phenotype of infected cells from lesions and lymph nodes of susceptible and resistant mice infected with Leishmania major.

Authors:  Eric Muraille; Carl De Trez; Bernard Pajak; Fabiola Aguilar Torrentera; Patrick De Baetselier; Oberdan Leo; Yves Carlier
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

2.  Biogenesis of Leishmania major-harboring vacuoles in murine dendritic cells.

Authors:  Ulrich Körner; Veronika Fuss; Jutta Steigerwald; Heidrun Moll
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

3.  Hierarchy of susceptibility of dendritic cell subsets to infection by Leishmania major: inverse relationship to interleukin-12 production.

Authors:  Sandrine Henri; Joan Curtis; Hubertus Hochrein; David Vremec; Ken Shortman; Emanuela Handman
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 4.  Imaging of the host/parasite interplay in cutaneous leishmaniasis.

Authors:  Owain R Millington; Elmarie Myburgh; Jeremy C Mottram; James Alexander
Journal:  Exp Parasitol       Date:  2010-05-23       Impact factor: 2.011

5.  Migratory dermal dendritic cells act as rapid sensors of protozoan parasites.

Authors:  Lai Guan Ng; Alice Hsu; Michael A Mandell; Ben Roediger; Christoph Hoeller; Paulus Mrass; Amaya Iparraguirre; Lois L Cavanagh; James A Triccas; Stephen M Beverley; Phillip Scott; Wolfgang Weninger
Journal:  PLoS Pathog       Date:  2008-11-28       Impact factor: 6.823

6.  Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity.

Authors:  E von Stebut; Y Belkaid; T Jakob; D L Sacks; M C Udey
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.